A Study on Cytomegalovirus (CMV) Infection Outcomes Among Hematopoietic Stem Cell Transplant (HSCT) Participants in Europe and Canada

CompletedOBSERVATIONAL
Enrollment

118

Participants

Timeline

Start Date

May 31, 2023

Primary Completion Date

January 31, 2024

Study Completion Date

January 31, 2024

Conditions
Cytomegalovirus (CMV)
Trial Locations (11)

3000

UZ Leuven, Leuven

8036

MU Graz, Graz

11000

University Clinical Center of Serbia, Belgrade

21000

Clinical Center of Vojvodina, Novi Sad

52621

Chaim Sheba Medical Center, Ramat Gan

3109601

Rambam Health Care Campus, Haifa

L8N 3Z5

Hamilton Health Sciences Corporation, Hamilton

H3H 2R9

McGill University Health Centre, Montreal

124 62

Attikon General University Hospital, Athens

570 10

George Papanikolau, Thessaloniki

02-776

Institute of Hematology and Transfusion Medicine (IHTM), Warsaw

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY